Description

Inhibitor of gastrin and gastric acid secretion that leads to a lowering of plasma calcium and phosphate levels by inhibiting bone reabsorption and excretion through the kidneys.

SEQUENCE: H-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2 (trifluoroacetate salt)
(Cys1 and 7 bridge)

ONE-LETTER SEQUENCE: CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge)

MOLECULAR FORMULA: C₁₅₁H₂₂₆N₄₀O₄₅S₃

MOLECULAR WEIGHT: 3417.9

STORAGE CONDITIONS: -20 ± 5 °C

CAS REGISTRY NUMBER: [21215-62-3]

SYNONYMS: Calcitonin M, human C carcinoma, Calcitonin, human reduced cyclic (1-7)-disulfide, Thyrocalcitonin, hCT

RESEARCH AREA: Osteoporosis

REFERENCES:
Y. Nakagawa, et al., Peptide Chemistry, 1976, 189 (1977)

SKU(s): OSTP-014A, OSTP-014B

KEYWORDS: hormone